Your browser doesn't support javascript.
loading
Results from a phase I/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy.
Pabst, Thomas; Vey, Norbert; Adès, Lionel; Bacher, Ulrike; Bargetzi, Mario; Fung, Samson; Gaidano, Gianluca; Gandini, Domenica; Hultberg, Anna; Johnson, Amy; Ma, Xuewen; Müller, Rouven; Nottage, Kerri; Papayannidis, Cristina; Recher, Christian; Riether, Carsten; Shah, Priya; Tryon, Jeffrey; Xiu, Liang; Ochsenbein, Adrian F.
Afiliación
  • Pabst T; Department of Medical Oncology, University Hospital, Inselspital and University of Bern, Bern. Thomas.Pabst@insel.ch.
  • Vey N; Hématologie Clinique, Institut Paoli-Calmettes, Marseille.
  • Adès L; Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris and Université Paris Cité, and Centre d'Investigation Clinique (INSERM CIC 1427), Paris.
  • Bacher U; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern.
  • Bargetzi M; Division of Hematology and Transfusion Medicine, Kantonsspital Aarau, Aarau.
  • Fung S; Fung Consulting Healthcare and Life Sciences, Eching.
  • Gaidano G; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont and Maggiore Hospital, Novara.
  • Gandini D; argenx, Ghent.
  • Hultberg A; argenx, Ghent.
  • Johnson A; Janssen Research and Development, Spring House, PA.
  • Ma X; Janssen Research and Development, Spring House, PA.
  • Müller R; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich.
  • Nottage K; Janssen RD, Raritan, NJ.
  • Papayannidis C; IRCCS, Azienda Ospedaliero Universitaria di Bologna, Istituto di Ematologia "L e A Seràgnoli", Bologna.
  • Recher C; Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Service d'Hématologie, Toulouse, France and Université Toulouse III Paul Sabatier, Toulouse.
  • Riether C; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Switzerland; Department of BioMedical Research (DBMR), University of Bern, Bern.
  • Shah P; Janssen RD, High Wycombe, Buckinghamshire.
  • Tryon J; Janssen RD, Raritan, NJ.
  • Xiu L; Janssen RD, Raritan, NJ.
  • Ochsenbein AF; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Switzerland; Department of BioMedical Research (DBMR), University of Bern, Bern.
Haematologica ; 108(7): 1793-1802, 2023 Jul 01.
Article en En | MEDLINE | ID: mdl-36779592
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Humans Idioma: En Revista: Haematologica Año: 2023 Tipo del documento: Article Pais de publicación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Humans Idioma: En Revista: Haematologica Año: 2023 Tipo del documento: Article Pais de publicación: Italia